Phase-I/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer

Bilal Piperdi, William V. Walsh, Kendra Bradley, Zheng Zhou, Venu Bathini, Meredith Hanrahan-Boshes, Lloyd Hutchinson, Roman Perez-Soler

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Phase-I/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences